U.S. Pharmacist Weekly News Update
September 12, 2018

DOAC-Related Bleeding Linked to Significantly Higher Cancer Risks

Bleeding is a concerning side effect of direct oral anticoagulants, but it also can be a useful predictor of other health conditions. That’s according to a recent conference presentation, which revealed that bleeding with anticoagulants signals a higher risk of cancer. Here are more details.


ADHD Diagnoses Dramatically Increase in U.S. Over 20 Years

How much ADHD diagnoses have increased over the last two decades likely won’t come as much of a surprise to pharmacists, who have been direct witnesses to the dramatic growth in prescriptions for ADHD drugs. Find out why researchers think that might be occurring.

Primary Care Physicians, Patients Often Aren’t Involved in
Drug Trials

Many of the drugs pharmacists dispense based on primary care prescriptions probably haven’t been tested in the types of patients receiving them. That’s according to a new study pointing out that very few FDA-approved medications are tested in primary care patients or tested in trials led by generalist physicians.

Majority of Survey Respondents Say Marijuana Beneficial for Health Condition
Is marijuana useful for conditions now treated with prescription drugs? Pharmacists might be surprised by how widespread that believe has become. Despite a lack of clinical evidence to that effect, a survey found that almost half of U.S. adults believe cannabis is beneficial for treating conditions such as epilepsy or multiple sclerosis. Here is more information.

Connect With U.S. Pharmacist
Facebook Twitter USP Google AppUSP Itunes App